Strides Pharma Inc. is recalling 678,829 bottles of Losartan Potassium Tablets (losartan), a blood pressure medication, because testing discovered levels of an AZIDO impurity that exceed acceptable limits. This voluntary recall affects three strengths of the medication (25 mg, 50 mg, and 100 mg) manufactured by Vivimed Life Sciences in India and distributed nationwide. No injuries or adverse incidents have been reported to date regarding this issue.
AZIDO impurities in medications are considered potential health risks when consumed at levels above strict safety limits over a long period. High levels of this impurity may be associated with an increased risk of harmful health effects, although no immediate injuries have been reported.
You have 2 options:
Distributed by Strides Pharma Inc.; Manufactured by Vivimed Life Sciences Private Limited.
Distributed by Strides Pharma Inc.; Manufactured by Vivimed Life Sciences Private Limited.
Distributed by Strides Pharma Inc.; Manufactured by Vivimed Life Sciences Private Limited.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.